Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals

Form 483

California, United StatesFEI 3013341563Issued December 20, 2019

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3013341563.

Observations9

Issue DateDecember 20, 2019

StatusNo Warning Letter

Establishment TypeProducer of Sterile Drug Products

Related Inspections0

Establishment Details

Firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals
Location: California, United States
FEI Number: 3013341563
Establishment Type: Producer of Sterile Drug Products
Product Type: Drugs
Issue Date: December 20, 2019
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals FDA Form 483, California, December 20, 2019